RT @AmericanHeartJ: Free PMC: Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digita…
Free PMC: Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry. https://t.co/tIJdocRh5S https://t.co/moxuwww9f4
RT @RobertAvramMD: #Digital approaches to conduct trials may be pertinent in the era of #COVID19 .In @AmericanHeartJ we describe our approa…
RT @RobertAvramMD: #Digital approaches to conduct trials may be pertinent in the era of #COVID19 .In @AmericanHeartJ we describe our approa…
RT @nl_pereira: Great collaboration between 2 great institutions @MayoClinic @UCSFMedicine implementing digital solutions in a clinical tri…
Great collaboration between 2 great institutions @MayoClinic @UCSFMedicine implementing digital solutions in a clinical trial
#Digital approaches to conduct trials may be pertinent in the era of #COVID19 .In @AmericanHeartJ we describe our approach to transitioning the TAILOR-PCI RCT to a Digital Registry: https://t.co/IxxlF6KnoR @UCSF @MayoClinic @nl_pereira @Jeffolgin @drmikef
RT @AmericanHeartJ: In Press: Rationale and Design of the TAILOR-PCI Digital Study: Transitioning a Randomized Controlled Trial to a Digita…
RT @AmericanHeartJ: In Press: Rationale and Design of the TAILOR-PCI Digital Study: Transitioning a Randomized Controlled Trial to a Digita…
In Press: Rationale and Design of the TAILOR-PCI Digital Study: Transitioning a Randomized Controlled Trial to a Digital Registry. https://t.co/Q9hsrUgnzV
Rationale & Design of TAILOR-PCI Digital Study: Transitioning a #RCT to Digital Registry Using digital technology to follow clinical trial pts & trial-related events which is especially pertinent during #COVID19 https://t.co/kZqsRmDmRY